Pamela McKay

36PUBLICATIONS
228CO-AUTHORS
Molecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.

Sridhar Chaganti, Christopher P Fox, Bernard D Maybury

Pageof 6

Frequent Collaborators

11 joint publications

Matthew Wilson

10 joint publications

Toby A Eyre

9 joint publications

Christopher P Fox

6 joint publications

Kate Cwynarski